Here's how JTD.AMEGROUPS.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

JTD . AMEGROUPS . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Jtd.amegroups.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://jtd.amegroups.org/article/view/8600/7942/post/category/interviews-with-guest-editors.

Title:
Tumor infiltrating lymphocytes in lung cancer: a new prognostic parameter - Reynders - Journal of Thoracic Disease
Description:
Tumor infiltrating lymphocytes in lung cancer: a new prognostic parameter
Website Age:
6 years and 6 months (reg. 2018-12-14).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is jtd.amegroups.org built with?

Custom-built

No common CMS systems were detected on Jtd.amegroups.org, but we identified it was custom coded using Bootstrap (CSS).

Traffic Estimate {📈}

What is the average monthly size of jtd.amegroups.org audience?

🚀 Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 59,823 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Jtd.amegroups.org Make Money? {💸}

We're unsure if the website is profiting.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Jtd.amegroups.org might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

cancer, tli, immune, tumor, prognostic, lung, crossref, pubmed, journal, patients, annals, lymphocytes, medicine, surgery, cell, therapy, cells, survival, predictive, infiltration, oncol, breast, tumorinfiltrating, set, translational, infiltrating, oncology, role, clinical, nonsmallcell, clin, ame, parameter, radiation, response, lymphocytic, validation, study, brambilla, intense, specific, chemotherapy, disease, research, maastricht, medical, jtd, interest, prognosis, years,

Topics {✒️}

triple-negative breast cancers precision medicine journal translational medicine art tumor-infiltrating foxp3+ regulatory small-cell lung carcinoma small-cell lung cancer facebook share tumor-infiltrating lymphocytes correlates biology-driven til subsets gastrointestinal oncology journal breast surgery annals maxillofacial anesthesia journal thoracic disease journal surgery australian journal spine surgery journal visualized surgery journal palliative medicine annals improved recurrence-free survival specific disease-free survival cd4+/cd8+ t-cells cardiothoracic surgery annals endoscopic surgery annals health policy journal early breast cancer invited commentary commissioned cancer cell nests specific lymphocytic subsets specific cell subset [crossref] [pubmed] ruffini [crossref] [pubmed] loi [crossref] [pubmed] adams [crossref] [pubmed] wakabayashi [crossref] [pubmed] hiraoka [crossref] [pubmed] shimizu [crossref] [pubmed] kilic [crossref] [pubmed] galon [crossref] [pubmed] cite cancer epidemiology annals nasopharynx cancer annals pancreatic cancer annals dendritic cell activation tumor-infiltrating lymphocytes tumor infiltrating lymphocytes tumour-infiltrating lymphocytes options open-access journal immune cell subset immune cell infiltrates immune cell subtypes tumor lymphocytic infiltration

Questions {❓}

  • Does this change prognostic and/or predictive impact of preoperatively determined TLI?

External Links {🔗}(106)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • AOS
  • Bootstrap
  • jQuery
  • Modernizr
  • Video.js

CDN Services {📦}

  • Amegroups

8.54s.